Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 1958 entries
View as:

A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01688635 Org: User:
Start: 09/30/12 End: 02/28/13 Due: 02/28/14

A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01924299 Org: User:
Start: 08/31/13 End: 11/30/13 Due: 11/30/14

A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00642018 Org: User:
Start: 03/31/08 End: 04/30/12 Due: 04/30/13

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Phase: N/A Priority: Normal
NCT ID: NCT00042562 Org: User:
Start: 12/31/02 End: 12/31/03 Due: 12/31/04

Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00103571 Org: User:
Start: 07/31/04 End: 08/31/06 Due: 08/31/07

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00192036 Org: User:
Start: 08/31/04 End: 11/30/09 Due: 11/30/10

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Phase: N/A Priority: Normal
NCT ID: NCT00190853 Org: User:
Start: 01/31/05 End: 09/30/06 Due: 09/30/07

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02561806 Org: User:
Start: 10/31/15 End: 10/31/17 Due: 10/31/18

A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness

Phase: N/A Priority: Normal
NCT ID: NCT04634409 Org: User:
Start: 10/29/20 End: 10/18/21 Due: 10/18/22

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Phase: N/A Priority: Normal
NCT ID: NCT06864026 Org: User:
Start: 03/06/25 End: 02/28/27 Due: 02/28/28

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06607185 Org: User:
Start: 10/21/24 End: 01/31/30 Due: 01/31/31

A Study of LY3045697 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01750853 Org: User:
Start: 01/31/13 End: 07/31/13 Due: 07/31/14

A Study of Evacetrapib and Digoxin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01897493 Org: User:
Start: 07/31/13 End: 09/30/13 Due: 09/30/14

Duloxetine for Multiple Sclerosis Pain

Phase: N/A Priority: Normal
NCT ID: NCT00755807 Org: User:
Start: 10/31/08 End: 11/30/10 Due: 11/30/11

Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature

Phase: N/A Priority: Normal
NCT ID: NCT00355030 Org: User:
Start: 06/30/06 End: 07/31/15 Due: 07/31/16

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT00216918 Org: User:
Start: 09/30/05 End: 06/30/06 Due: 06/30/07

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00087698 Org: User:
Start: 09/30/03 End: 02/29/08 Due: 02/28/09

Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia

Phase: N/A Priority: Normal
NCT ID: NCT00716274 Org: User:
Start: 09/30/08 End: 07/31/16 Due: 07/31/17

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02891226 Org: User:
Start: 12/14/16 End: 02/05/21 Due: 02/05/22

A Study of Injections of LY3074828 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03886948 Org: User:
Start: 03/27/19 End: 10/04/19 Due: 10/04/20

A Study of LY3084077 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01846702 Org: User:
Start: 05/31/13 End: 12/31/13 Due: 12/31/14

A Study of Lasmiditan in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04749914 Org: User:
Start: 02/15/21 End: 07/06/21 Due: 07/06/22

A Device Study in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04848402 Org: User:
Start: 09/27/21 End: 07/22/22 Due: 07/22/23

A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03559270 Org: User:
Start: 06/27/18 End: 06/13/22 Due: 06/13/23

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

Phase: N/A Priority: Normal
NCT ID: NCT01621178 Org: User:
Start: 07/31/12 End: 12/31/16 Due: 12/31/17